特发性肺纤维化中与慢步速相关的表型特征
该研究在四个特发性肺纤维化(IPF)前瞻性队列中评估4米步行速度(4MGS)的可靠性、同时效度和对肺康复的反应性,并按慢步速(<0.8 m/s)分层比较表型特征。结果显示4MGS信度高,与6分钟步行距离(6MWD)强相关,肺康复后显著改善;慢步速患者运动表现、呼吸困难、健康状况和预后指数更差,而肺功能和HRCT参数相似。
要点
- 4MGS在IPF中信度高、效度好,可作为简单功能评估工具。
- 慢步速(<0.8 m/s)患者运动表现、呼吸困难、健康状况和预后更差。
- 肺康复可显著改善IPF患者的4MGS。
核心结论
- 4MGS是简单、可靠、有效且反应性好的工具,可识别稳定IPF中运动表现、呼吸困难、健康状况和预后指数更差的表型。
研究设计与样本
- 在四个IPF前瞻性队列中评估4MGS的观察者间信度(n=46)、重测信度(n=46)、同时效度(n=65和n=62)和对肺康复的反应性(n=60)。
- 按慢4MGS(<0.8 m/s)分层比较所有患者的表型特征,包括肺功能、胸部HRCT、6MWD、MRC呼吸困难评分、KBILD问卷和GAP预后指数。
主要发现
- 观察者间和重测的组内相关系数分别为0.996和0.983。
- 4MGS与6MWD强相关(r=0.76;P<0.0001),与MRC(r=-0.56)、KBILD(r=0.44)和GAP指数(r=-0.41)中度相关;所有P<0.005。
- 肺康复后4MGS显著改善,平均(95%CI)变化为0.16(0.12-0.20)m/s,效应量为0.65。
- 慢步速患者较步速保留者运动表现更差(6MWD:-167(-220至-133)m),呼吸困难、健康状况和预后指数也更差,尽管肺功能和HRCT参数相似。
临床怎么用
- 4MGS可用于稳定IPF患者的功能评估,慢步速(<0.8 m/s)提示运动表现、呼吸困难、健康状况和预后更差。
- 4MGS可作为肺康复效果的评价指标之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Usual gait speed over 4 m (4MGS) is an established functional performance measure in older adults that consistently predicts adverse health outcomes, but few data exist in idiopathic pulmonary fibrosis (IPF). We assessed the reliability of 4MGS, its relationship with established outcome measures and its responsiveness to pulmonary rehabilitation. METHODS: In four prospective IPF cohorts, 4MGS inter-observer (n = 46) and test-retest (n = 46) reliability, concurrent validity (n = 65 and n = 62) and responsiveness (n = 60) were determined. The phenotypic characteristics of all patients stratified according to slow 4MGS (<0.8 m/s) were compared, including lung function parameters, HRCT of the chest, 6-min walking distance (6MWD), Medical Respiratory Council (MRC) dyspnoea score, King's Brief Interstitial Lung Disease (KBILD) questionnaire and Gender, Age and lung Physiology (GAP) prognostic index. RESULTS: Intra-class correlation coefficients for inter-observer and test-retest reliability were 0.996 and 0.983, respectively. There was a strong association between 4MGS and 6MWD (r = 0.76; P < 0.0001) and moderate correlations with MRC (r = -0.56), KBILD (r = 0.44) and GAP index (r = -0.41); all P < 0.005. 4MGS improved significantly with pulmonary rehabilitation (mean (95% CI) change: 0.16 (0.12-0.20) m/s), effect size 0.65. Patients with slow 4MGS had significantly worse exercise performance (6MWD: -167 (-220 to -133) m), dyspnoea, health status and prognosis index than those with preserved 4MGS, despite similar lung function and HRCT parameters. CONCLUSION: 4MGS is a simple, reliable, valid and responsive tool that may detect a patient phenotype with worse exercise performance, dyspnoea, health status and prognosis index in stable IPF.
引用
- Nolan CM, Maddocks M, Maher TM, et al. Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis. Respirology. 2017. PMID: 29139195. doi:10.1111/resp.13213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。